Hawkins Inc (HWKN) Drops 5.99% on January 25

Equities Staff  |

Hawkins Inc (HWKN) was one of the Russell 2000's biggest losers for Monday January 25 as the stock slid 5.99% to $33.42, a loss of $-2.13 per share. Starting at an opening price of $35.29 a share, the stock traded between $33.42 and $35.59 over the course of the trading day. Volume was 44,959 shares over 524 trades, against an average daily volume of 23,443 shares and a total float of 10.55 million.

The losses send Hawkins Inc down to a market cap of $352.49 million. In the last year, Hawkins Inc has traded between $44.00 and $33.32, and its 50-day SMA is currently $37.58 and 200-day SMA is $38.84.

The stock has a P/E Ratio of 19.2.

Hawkins Inc distributes bulk chemicals and blends, manufactures and distributes specialty chemicals for its customers in various industries.

Hawkins Inc is based out of Roseville, MN and has some 419 employees. Its CEO is Patrick H. Hawkins.

For a complete fundamental analysis analysis of Hawkins Inc, check out Equities.com’s Stock Valuation Analysis report for HWKN. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Dr Oliver Krause Founder Untitled Inc Part 1

Matt Bird sits down with Dr Oliver Krause, Founder Untitled Inc, in part 1 of this 2 part interview at the World Economic Forum at Davos 2019

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…